BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23840194)

  • 1. The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds.
    Duplantier AJ; van Hoek ML
    Front Immunol; 2013; 4():143. PubMed ID: 23840194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Komodo dragon-inspired synthetic peptide DRGN-1 promotes wound-healing of a mixed-biofilm infected wound.
    Chung EMC; Dean SN; Propst CN; Bishop BM; van Hoek ML
    NPJ Biofilms Microbiomes; 2017; 3():9. PubMed ID: 28649410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37.
    Dean SN; Bishop BM; van Hoek ML
    Front Microbiol; 2011; 2():128. PubMed ID: 21772832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent.
    Ridyard KE; Overhage J
    Antibiotics (Basel); 2021 May; 10(6):. PubMed ID: 34072318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wound Healing and Antibacterial Activity of Five Ethnomedical Calophyllum inophyllum Oils: An Alternative Therapeutic Strategy to Treat Infected Wounds.
    Léguillier T; Lecsö-Bornet M; Lémus C; Rousseau-Ralliard D; Lebouvier N; Hnawia E; Nour M; Aalbersberg W; Ghazi K; Raharivelomanana P; Rat P
    PLoS One; 2015; 10(9):e0138602. PubMed ID: 26406588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of the cathelicidin peptide LL-37 in a non-healing wound environment.
    Grönberg A; Zettergren L; Agren MS
    Acta Derm Venereol; 2011 Sep; 91(5):511-5. PubMed ID: 21547341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snake Cathelicidin NA-CATH and Smaller Helical Antimicrobial Peptides Are Effective against Burkholderia thailandensis.
    Blower RJ; Barksdale SM; van Hoek ML
    PLoS Negl Trop Dis; 2015; 9(7):e0003862. PubMed ID: 26196513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Chronic Wound Healing by Anti-biofilm Peptides and Protease.
    Ghoreishi FS; Roghanian R; Emtiazi G
    Adv Pharm Bull; 2022 May; 12(3):424-436. PubMed ID: 35935044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model.
    Simonetti O; Cirioni O; Goteri G; Lucarini G; Kamysz E; Kamysz W; Orlando F; Rizzetto G; Molinelli E; Morroni G; Ghiselli R; Provinciali M; Giacometti A; Offidani A
    Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Antimicrobial Peptide, RP557, for the Broad-Spectrum Treatment of Wound Pathogens and Biofilm.
    Woodburn KW; Jaynes JM; Clemens LE
    Front Microbiol; 2019; 10():1688. PubMed ID: 31396193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections.
    Majewski K; Kozłowska E; Żelechowska P; Brzezińska-Błaszczyk E
    Cent Eur J Immunol; 2018; 43(4):453-457. PubMed ID: 30799994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen tethering of synthetic human antimicrobial peptides cathelicidin LL37 and its effects on antimicrobial activity and cytotoxicity.
    Lozeau LD; Grosha J; Kole D; Prifti F; Dominko T; Camesano TA; Rolle MW
    Acta Biomater; 2017 Apr; 52():9-20. PubMed ID: 28017866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Staphylococcal Biofilm Effects of Human Cathelicidin Peptides.
    Mishra B; Golla RM; Lau K; Lushnikova T; Wang G
    ACS Med Chem Lett; 2016 Jan; 7(1):117-21. PubMed ID: 26819677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-Based Hydrogel for the Dual Delivery of Antimicrobial Agents Against Bacterial Methicillin-Resistant
    Fasiku VO; Omolo CA; Devnarain N; Ibrahim UH; Rambharose S; Faya M; Mocktar C; Singh SD; Govender T
    ACS Omega; 2021 Aug; 6(34):21994-22010. PubMed ID: 34497894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vivo polymicrobial biofilm wound infection model to study interspecies interactions.
    Dalton T; Dowd SE; Wolcott RD; Sun Y; Watters C; Griswold JA; Rumbaugh KP
    PLoS One; 2011; 6(11):e27317. PubMed ID: 22076151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage therapy for Staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care.
    Seth AK; Geringer MR; Nguyen KT; Agnew SP; Dumanian Z; Galiano RD; Leung KP; Mustoe TA; Hong SJ
    Plast Reconstr Surg; 2013 Feb; 131(2):225-234. PubMed ID: 23357984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs.
    Kuroda K; Okumura K; Isogai H; Isogai E
    Front Oncol; 2015; 5():144. PubMed ID: 26175965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wound healing mechanism of antimicrobial peptide cathelicidin-DM.
    Wang G; Chen Z; Tian P; Han Q; Zhang J; Zhang AM; Song Y
    Front Bioeng Biotechnol; 2022; 10():977159. PubMed ID: 36425652
    [No Abstract]   [Full Text] [Related]  

  • 19. Chitosan-based nitric oxide-releasing dressing for anti-biofilm and in vivo healing activities in MRSA biofilm-infected wounds.
    Choi M; Hasan N; Cao J; Lee J; Hlaing SP; Yoo JW
    Int J Biol Macromol; 2020 Jan; 142():680-692. PubMed ID: 31622708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Switchable Antimicrobial Nanofiber Networks of Hydrogel Eradicate Biofilm and Rescue Stalled Healing in Chronic Wounds.
    Wang J; Chen XY; Zhao Y; Yang Y; Wang W; Wu C; Yang B; Zhang Z; Zhang L; Liu Y; Du X; Li W; Qiu L; Jiang P; Mou XZ; Li YQ
    ACS Nano; 2019 Oct; 13(10):11686-11697. PubMed ID: 31490650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.